APEX2
Basic information
Region (hg38): X:55000363-55009057
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the APEX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 15 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 8 | 3 |
Variants in APEX2
This is a list of pathogenic ClinVar variants found in the APEX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-55000540-G-C | not specified | Uncertain significance (Jun 03, 2024) | ||
X-55000558-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
X-55001565-C-T | Benign (Aug 09, 2018) | |||
X-55001609-G-A | not specified | Uncertain significance (May 21, 2024) | ||
X-55001614-C-T | not specified | Uncertain significance (Jul 30, 2024) | ||
X-55002258-C-T | Benign (Dec 31, 2019) | |||
X-55002275-A-G | not specified | Likely benign (Oct 09, 2024) | ||
X-55002323-C-G | not specified | Uncertain significance (Dec 16, 2023) | ||
X-55002349-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
X-55002382-C-T | not specified | Uncertain significance (Dec 05, 2022) | ||
X-55002385-G-T | not specified | Uncertain significance (May 13, 2022) | ||
X-55002430-C-T | Likely benign (Jul 06, 2018) | |||
X-55002973-G-T | not specified | Uncertain significance (Jun 26, 2024) | ||
X-55003018-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
X-55003066-G-A | not specified | Uncertain significance (Dec 03, 2024) | ||
X-55003070-G-T | not specified | Uncertain significance (Aug 28, 2023) | ||
X-55003812-C-T | Likely benign (Jan 01, 2023) | |||
X-55003842-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
X-55006594-A-C | not specified | Uncertain significance (Mar 04, 2024) | ||
X-55006595-T-A | not specified | Uncertain significance (Aug 16, 2022) | ||
X-55006683-C-T | Likely benign (Mar 01, 2023) | |||
X-55006691-C-A | not specified | Uncertain significance (Dec 06, 2021) | ||
X-55006713-G-T | not specified | Uncertain significance (Jan 19, 2024) | ||
X-55006805-A-G | Benign (Jul 03, 2018) | |||
X-55006857-C-T | not specified | Uncertain significance (Apr 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
APEX2 | protein_coding | protein_coding | ENST00000374987 | 6 | 8701 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.973 | 0.0270 | 125662 | 0 | 3 | 125665 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.564 | 177 | 199 | 0.888 | 0.0000161 | 3365 |
Missense in Polyphen | 39 | 57.828 | 0.67442 | 988 | ||
Synonymous | -0.746 | 85 | 76.7 | 1.11 | 0.00000576 | 1058 |
Loss of Function | 3.09 | 0 | 11.1 | 0.00 | 7.74e-7 | 213 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000365 | 0.0000365 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000722 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000122 | 0.00000880 |
Middle Eastern | 0.0000722 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Function as a weak apurinic/apyrimidinic (AP) endodeoxyribonuclease in the DNA base excision repair (BER) pathway of DNA lesions induced by oxidative and alkylating agents. Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. Displays also double-stranded DNA 3'-5' exonuclease, 3'-phosphodiesterase activities. Shows robust 3'-5' exonuclease activity on 3'-recessed heteroduplex DNA and is able to remove mismatched nucleotides preferentially. Shows fairly strong 3'-phosphodiesterase activity involved in the removal of 3'-damaged termini formed in DNA by oxidative agents. In the nucleus functions in the PCNA-dependent BER pathway. Required for somatic hypermutation (SHM) and DNA cleavage step of class switch recombination (CSR) of immunoglobulin genes. Required for proper cell cycle progression during proliferation of peripheral lymphocytes. {ECO:0000269|PubMed:11376153, ECO:0000269|PubMed:16687656, ECO:0000269|PubMed:19443450}.;
- Pathway
- Base excision repair - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.54
Haploinsufficiency Scores
- pHI
- 0.0745
- hipred
- Y
- hipred_score
- 0.831
- ghis
- 0.604
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.206
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Apex2
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- base-excision repair;DNA recombination;cell cycle;nucleic acid phosphodiester bond hydrolysis
- Cellular component
- fibrillar center;nucleus;mitochondrion;intracellular membrane-bounded organelle
- Molecular function
- DNA binding;DNA-(apurinic or apyrimidinic site) endonuclease activity;endonuclease activity;phosphodiesterase I activity;zinc ion binding;double-stranded DNA 3'-5' exodeoxyribonuclease activity;class I DNA-(apurinic or apyrimidinic site) endonuclease activity